In the new format, it would've as it wouldn't have qualified under the 505b2, as Zantrene would've been dosed in combo.. So they would've had to go through the whole clinical pathway.
ill be interested to see what they will do with AML now.
Ann: Race Board and Management Team Changes, page-353
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.73 |
Change
0.170(10.9%) |
Mkt cap ! $294.7M | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.73 | $1.57 | $550.9K | 332.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 999 | 1 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |